Literature DB >> 24009962

Evaluation of tissue doppler echocardiography and T2* magnetic resonance imaging in iron load of patients with thalassemia major.

Mehrdad Saravi1, Ahmad Tamadoni, Rozita Jalalian, Hassan Mahmoodi-Nesheli, Mosatafa Hojati, Saeed Ramezani.   

Abstract

BACKGROUND: Iron-mediated cardiomyopathy is the main complication of thalassemia major (TM) patients. Therefore, there is an important clinical need in the early diagnosis and risk stratification of patients. The aim of this study was to evaluate the efficacy of tissue doppler imaging (TDI) to study cardiac iron overload in patients with TM using T2* magnetic resonance (MR) as the gold-standard non-invasive diagnostic test.
METHODS: A total of 100 TM patients with the mean age of 19±7 years and 100 healthy controls 18.8±7 years were evaluated. Conventional echocardiography, TDI, and cardiac MRI T2* were performed in all subjects. TDI measures included myocardial systolic (Sm), early (Em) and late (Am) diastolic velocities at basal and middle segments of septal and lateral LV wall. The TM patients were also subgrouped according to those with iron load (T2* ≤ 20 ms) and those without (T2* > 20 ms), and also severe (T2* ≤ 10 ms) versus the non-severe (T2* ≤ 10 ms).
RESULTS: Using T2* cardiovascular MR, abnormal myocardial iron load (T2* ≤ 20 ms) was detected in 84% of the patients and among these, 50% (42/84) had severe (T2* ≤ 10 ms) iron load. The mean T2* was 11.6±8.6 ms (5-36.7). A negative linear correlation existed between transfusion period of patients and T2* levels (r = -0.53, p=0.02). The following TDI measures were lower in patients than in controls: basal septal Am (p<0.05), mid-septal Em and Am (p<0.05), basal lateral Am (p<0.05), mid-lateral LV wall Sm (p<0.05) and Am (p<0.05).
CONCLUSION: Tissue doppler imaging is helpful in predicting the presence of myocardial iron load in Thalassemia patients. Therefore, it can be used for screening of thalassemia major patients.

Entities:  

Keywords:  Iron overload; MRI; T2* MRI; Thalassemia major; Tissue doppler imaging

Year:  2013        PMID: 24009962      PMCID: PMC3755834     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  28 in total

1.  Evaluation of cardiac functions in patients with thalassemia major.

Authors:  N O Küçük; G Aras; T Sipahi; E Ibiş; N Akar; A Soylu; G Erbay
Journal:  Ann Nucl Med       Date:  1999-06       Impact factor: 2.668

2.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

3.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

4.  Early impairment of myocardial function in young patients with beta-thalassemia major.

Authors:  Damiano Magrì; Susanna Sciomer; Francesco Fedele; Gianfranco Gualdi; Emanuele Casciani; Pellegrina Pugliese; Anna Losardo; Giancarlo Ferrazza; Eleonora Pasquazzi; Erika Schifano; Eleonora Mussino; Raffaele Quaglione; Gianfranco Piccirillo
Journal:  Eur J Haematol       Date:  2008-02-12       Impact factor: 2.997

5.  Early detection of myocardial dysfunction in children with beta-thalassaemia major.

Authors:  Tayfun Uçar; Talia Ileri; Semra Atalay; Zümrüt Uysal; Ercan Tutar; Mehmet Ertem
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-24       Impact factor: 2.357

6.  comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major.

Authors:  Vassilios Perifanis; Athanasios Christoforidis; Efthimia Vlachaki; Ioanna Tsatra; George Spanos; Miranda Athanassiou-Metaxa
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

7.  Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Authors:  Dimitrios Th Kremastinos; Eftihia Hamodraka; John Parissis; Dimitrios Tsiapras; Kleanthi Dima; Alan Maisel
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

8.  Tissue doppler imaging and NT-proBNP levels show the early impairment of ventricular function in patients with beta-thalassaemia major.

Authors:  Onur Akpinar; Esmeray Acartürk; Mehmet Kanadaşi; Cağatay Unsal; Fikri Başlamişli
Journal:  Acta Cardiol       Date:  2007-06       Impact factor: 1.718

9.  Early detection of iron overload in the heart: a key role for MRI!

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2009-11-24       Impact factor: 2.357

10.  T2 relaxation time study of iron overload in b-thalassemia.

Authors:  S I Mavrogeni; E D Gotsis; V Markussis; N Tsekos; C Politis; E Vretou; D Kermastinos
Journal:  MAGMA       Date:  1998-08       Impact factor: 2.533

View more
  3 in total

1.  Correlation between Myocardial Iron Overload Detected by CMRT2* and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients with Thalassemia Major.

Authors:  Mehdi Najimi; Yazdan Ghandi; Sarvenaz Mehrabi; Aziz Eghbali; Danial Habibi
Journal:  J Cardiovasc Echogr       Date:  2022-04-20

2.  The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.

Authors:  Iain C Macdougall; Naomi V Dahl; Kristine Bernard; Zhu Li; Alka Batycky; William E Strauss
Journal:  BMC Nephrol       Date:  2017-04-03       Impact factor: 2.388

3.  Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients.

Authors:  Pandji Irani Fianza; Anita Rahmawati; Sri Hudaya Widihastha; Shofura Afifah; Mohammad Ghozali; Andre Indrajaya; Dilli Marayuzan Akbar Pratama; Dimmy Prasetya; Teddy Arnold Sihite; Mas Rizky A A Syamsunarno; Djatnika Setiabudi; Suthat Fucharoen; Ramdan Panigoro
Journal:  Anemia       Date:  2021-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.